Results of treatment with an intensive induction regimen using idarubicin in combination with cytarabine and etoposide in children with acute myeloblastic leukemia
- 31 December 1996
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 20 (11-12) , 973-981
- https://doi.org/10.1016/s0145-2126(96)00071-9
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Treatment of Patients with Acute Myelogenous LeukemiaJournal of Pediatric Hematology/Oncology, 1995
- The Value of Scoring Systems for the Diagnosis of Biphenotypic Leukemia and Mature B-Cell DisordersLeukemia & Lymphoma, 1994
- Klassifikation der AML nach morphologischen, immunologischen und zytogenetischen KriterienKlinische Padiatrie, 1993
- Reassessing the hemostatic disorder associated with acute promyelocytic leukemia [see comments]Blood, 1992
- Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemiaBlood, 1992
- Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemiaBlood, 1991
- Idarubicin (4-demethoxydaunorubicin)Investigational New Drugs, 1986
- ACUTE PROMYELOCYTIC LEUKAEMIA: HAEMORRHAGIC MANIFESTATION AND MORPHOLOGIC CRITERIABritish Journal of Haematology, 1975
- Studies of the Procoagulant and Fibrinolytic Activity of Promyelocytes in Acute Promyelocytic LeukaemiaBritish Journal of Haematology, 1973
- Coagulation defects in acute promyelocytic leukemiaArchives of internal medicine (1960), 1969